Ericsson; Anna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ericsson; Anna.The latest application filed is for "activating pyruvate kinase r".

Company Profile

35.29.51

Ericsson; Anna - Shrewsbury MA
Ericsson; Anna - Acton MA
Ericsson; Anna - Quebec CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Activating Pyruvate Kinase R App 20220304987 - Ericsson; Anna ; et al.	2022-09-29
Inhibiting Cyclic Amp-responsive Element-binding Protein (creb) App 20220213089 - SCHILLER; Shawn E.R. ; et al.	2022-07-07
Tetrahydro-imidazo Quinoline Compositions As Cbp/p300 Inhibitors App 20220169647 - Schiller; Shawn E.R. ; et al.	2022-06-02
Inhibiting Creb Binding Protein (cbp) App 20220162207 - Schiller; Shawn E.R. ; et al.	2022-05-26
Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors Grant 11,292,791 - Schiller , et al. April 5, 2	2022-04-05
Activating Pyruvate Kinase R App 20220087983 - Ericsson; Anna ; et al.	2022-03-24
Bromodomain Inhibitors For Androgen Receptor-driven Cancers App 20220088005 - GUICHARD; Sylvie ; et al.	2022-03-24
Inhibiting CREB binding protein (CBP) Grant 11,254,674 - Schiller , et al. February 22, 2	2022-02-22
Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound App 20220031671 - ERICSSON; Anna ; et al.	2022-02-03
Inhibiting Ubiquitin Specific Peptidase 9x App 20210346356 - LYNES; Maureen ; et al.	2021-11-11
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20210332052 - Ioannidis; Stephanos ; et al.	2021-10-28
Activating Pyruvate Kinase R App 20210308108 - Ericsson; Anna ; et al.	2021-10-07
Pyrrolopyrrole Compositions As Pyruvate Kinase (pkr) Activators App 20210246143 - ERICSSON; Anna ; et al.	2021-08-12
Activating pyruvate kinase R Grant 11,071,725 - Ericsson , et al. July 27, 2	2021-07-27
Activating Pyruvate Kinase R And Mutants Thereof App 20210221816 - Lancia, JR.; David R. ; et al.	2021-07-22
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators Grant 11,014,927 - Ericsson , et al. May 25, 2	2021-05-25
Activating pyruvate kinase R and mutants thereof Grant 11,001,588 - Lancia, Jr. , et al. May 11, 2	2021-05-11
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20210078973 - Lin; Jian ; et al.	2021-03-18
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,934,299 - Ioannidis , et al. March 2, 2	2021-03-02
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,889,567 - Lin , et al. January 12, 2	2021-01-12
Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound App 20200405699 - ERICSSON; Anna ; et al.	2020-12-31
Inhibiting CREB binding protein (CBP) Grant 10,870,648 - Schiller , et al. December 22, 2	2020-12-22
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors Grant 10,807,976 - Lin , et al. October 20, 2	2020-10-20
Inhibiting Creb Binding Protein (cbp) App 20200299295 - Schiller; Shawn E.R. ; et al.	2020-09-24
Activating Pyruvate Kinase R App 20200253939 - Kind Code	2020-08-13
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20200223822 - Lin; Jian ; et al.	2020-07-16
Tetrahydro-imidazo Quinoline Compositions As Cbp/p300 Inhibitors App 20200216445 - Schiller; Shawn E.R. ; et al.	2020-07-09
Activating pyruvate kinase R Grant 10,675,274 - Ericsson , et al.	2020-06-09
Treating Sickle Cell Disease With A Pyruvate Kinase R Activating Compound App 20200129485 - Ericsson; Anna ; et al.	2020-04-30
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20200115343 - Lin; Jian ; et al.	2020-04-16
Activating Pyruvate Kinase R App 20200085798 - Ericsson; Anna ; et al.	2020-03-19
Activating Pyruvate Kinase R And Mutants Thereof App 20200087309 - Lancia, JR.; David R. ; et al.	2020-03-19
Pyrrolopyrrole Compositions As Pyruvate Kinase (pkr) Activators App 20200069643 - ERICSSON; Anna ; et al.	2020-03-05
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,577,329 - Lin , et al.	2020-03-03
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,550,098 - Lin , et al. Fe	2020-02-04
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors Grant 10,550,099 - Lin , et al. Fe	2020-02-04
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors App 20200010464 - Lin; Jian ; et al.	2020-01-09
Inhibiting Creb Binding Protein (cbp) App 20200002332 - Schiller; Shawn E.R. ; et al.	2020-01-02
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20190367525 - Ioannidis; Stephanos ; et al.	2019-12-05
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,414,752 - Lin , et al. Sept	2019-09-17
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors Grant 10,407,419 - Lin , et al. Sept	2019-09-10
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors App 20190263779 - Lin; Jian ; et al.	2019-08-29
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20190263778 - Lin; Jian ; et al.	2019-08-29
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,377,760 - Ioannidis , et al. A	2019-08-13
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors App 20190210995 - Lin; Jian ; et al.	2019-07-11
Phenyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20190210970 - Lin; Jian ; et al.	2019-07-11
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20190202790 - Lin; Jian ; et al.	2019-07-04
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,294,206 - Lin , et al.	2019-05-21
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20190135781 - Lin; Jian ; et al.	2019-05-09
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors Grant 10,280,150 - Lin , et al.	2019-05-07
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,266,495 - Lin , et al.	2019-04-23
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,253,015 - Lin , et al.	2019-04-09
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20180339988 - Ioannidis; Stephanos ; et al.	2018-11-29
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20180327382 - Lin; Jian ; et al.	2018-11-15
Phenyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20180327361 - Lin; Jian ; et al.	2018-11-15
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20180312487 - Lin; Jian ; et al.	2018-11-01
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 10,005,734 - Lin , et al. June 26, 2	2018-06-26
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20180141910 - Lin; Jian ; et al.	2018-05-24
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors App 20180134682 - Lin; Jian ; et al.	2018-05-17
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors App 20180118732 - Lin; Jian ; et al.	2018-05-03
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20180086733 - Lin; Jian ; et al.	2018-03-29
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 9,902,728 - Ioannidis , et al. February 27, 2	2018-02-27
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 9,834,539 - Lin , et al. December 5, 2	2017-12-05
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors Grant 9,815,817 - Lin , et al. November 14, 2	2017-11-14
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 9,771,349 - Lin , et al. September 26, 2	2017-09-26
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20170174658 - LIN; Jian ; et al.	2017-06-22
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors Grant 9,624,216 - Lin , et al. April 18, 2	2017-04-18
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant 9,624,175 - Lin , et al. April 18, 2	2017-04-18
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20160311774 - Lin; Jian ; et al.	2016-10-27
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors App 20160311818 - Lin; Jian ; et al.	2016-10-27
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20160185785 - Ioannidis; Stephanos ; et al.	2016-06-30
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20160083366 - Lin; Jian ; et al.	2016-03-24
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20160083349 - Lin; Jian ; et al.	2016-03-24
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors App 20160083367 - Lin; Jian ; et al.	2016-03-24
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors App 20160083365 - Lin; Jian ; et al.	2016-03-24
Kinase inhibitors as therapeutic agents App 20060074102 - Cusack; Kevin ; et al.	2006-04-06
Aminobenzoxazoles as therapeutic agents App 20060025383 - Wishart; Neil ; et al.	2006-02-02
Compounds having retinoid-like activity Grant 6,825,233 - Ericsson , et al. November 30, 2	2004-11-30
Compounds having retinoid-like activity App 20020193421 - Ericsson, Anna ; et al.	2002-12-19
Retinoid-like compounds Grant 5,945,561 - Starrett, Jr. , et al. August 31, 1	1999-08-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.